Bone Density Loss: Tenofovir has actually been linked to a reduce in bone mineral density, increasing the risk of bone complications or fractures.HIV-1 infected subjects on dolutegravir monotherapy demonstrated swift and dose-dependent reduction of antiviral action with declines of HIV-1 RNA copies for each ml. The antiviral reaction was managed fo… Read More